IMNM
Immunome Inc
25.10$
+4.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 9.5% | 5.2% | 23.2% | 42.6% | |
| – | – | – | – | -9.5% | 100.0% | 100.0% | 57.4% | |
| – | – | – | – | 351.2% | 164.7% | 1,432.8% | 2,511.6% | |
| – | – | – | – | 205.7% | 140.2% | 364.5% | 630.6% | |
| – | – | – | – | 556.8% | 881.4% | 3,482.4% | 3,142.2% | |
| – | – | – | – | -556.8% | -781.4% | -3,382.4% | -3,084.8% | |
| – | – | – | – | 0.1% | – | – | – | |
| – | – | – | – | -556.8% | -761.9% | -3,240.4% | -3,060.0% | |
| – | – | – | – | 9.3% | 4.0% | -3,240.4% | – | |
| – | – | – | – | -556.8% | -761.9% | -3,240.4% | -3,060.0% | |
| – | – | – | – | -547.2% | -199.7% | -1,674.1% | -3,017.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.